Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Chief Executive Officer 62 19/10/2022
President 61 29/03/2021
Comptroller/Controller/Auditor 65 12/08/2024
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 -
Director/Board Member 58 29/03/2022
Change 5-day change 1-year change 3-year change Capi.($)
+61.97%+49.35% - - 403K
+0.11%-3.67%+17.30%-18.82% 62.28B
+1.44%+5.33%+68.08%+223.49% 60.59B
+0.70%+29.50%+29.50%+29.50% 39.55B
+0.26%+9.80%-55.40%-64.79% 36.8B
+0.05%+2.41%+51.20%-36.17% 29.53B
+0.65%+6.01%+56.79%+74.77% 21.68B
+0.54%+5.21%+82.49%-59.59% 19.8B
+4.80%-0.20%-5.33%+112.95% 16.96B
+0.18%-1.66%+49.80%+101.47% 16.16B
Average +7.07%+3.10%+32.71%+40.31% 33.71B
Weighted average by Cap. +0.80%+2.99%+31.06%+46.41%
Logo SL Therapeutics, Inc.
SL Therapeutics Inc, formerly Stem Lab Inc, is a Korea-based company principally engaged in the manufacture and sale of biopharmaceuticals. The Company is principally engaged in the development, research, manufacture and sale of biopharmaceuticals such as stem cell culture mediums, stem cell treatment as well as others.
Employees
-
  1. Stock Market
  2. Stocks
  3. A258540 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!